Ginkgo Bioworks Holdings, Inc. (DNABW)

Market Cap	680.51M
Revenue (ttm)	217.95M
Net Income (ttm)	-651.19M
Shares Out	n/a
EPS (ttm)	-12.86
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,150
Average Volume	34,218
Open	0.0081
Previous Close	0.0119
Day's Range	0.0081 - 0.0081
52-Week Range	0.0005 - 0.0249
Beta	n/a
RSI	47.69
Earnings Date	Feb 28, 2025

About Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2008
• Employees: 834
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNABW